🇺🇸 FDA
Patent

US 9856260

Compounds useful for inhibiting metastasis from cancer and methods using same

granted A61KA61K31/451A61K31/453

Quick answer

US patent 9856260 (Compounds useful for inhibiting metastasis from cancer and methods using same) held by Alliance Discovery, Inc. expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Alliance Discovery, Inc.
Grant date
Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/451, A61K31/453, A61K31/7088, A61K39/3955